Detection of prostate cancer in men with prostate-specific antigen (PSA) levels of 2.0 to 4.0ng/ml is equivalent to that in men with 4.1 to 10.0ng/ml in a Japanese population

被引：0
|
作者：
Kobayashi, T
Nishizawa, K
Mitsumori, K
Ogura, K
Ide, Y
机构：
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)39002-5
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：478 / 479
页数：2
相关论文
共 50 条
  • [21] A "PSA Pyramid'' for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening
    Randazzo, Marco
    Beatrice, Josef
    Huber, Andreas
    Grobholz, Rainer
    Manka, Lukas
    Chun, Felix K.
    Recker, Franz
    Kwiatkowski, Maciej
    EUROPEAN UROLOGY, 2015, 68 (04) : 591 - 597
  • [22] T1c prostate cancer detection rate and pathologic characteristics: Comparison between patients with serum prostate-specific antigen range of 3.0 to 4.0 ng/mL and 4.1 to 10.0 ng/mL in Korean population
    Park, Hyoung Keun
    Hong, Sung Kyu
    Byun, Seok-Soo
    Lee, Sang Eun
    UROLOGY, 2006, 68 (01) : 85 - 88
  • [23] Predicting Prostate Biopsy Result in Men With Prostate Specific Antigen 2.0 to 10.0 ng/ml Using an Investigational Prostate Cancer Methylation Assay
    Baden, Jonathan
    Adams, Scott
    Astacio, Tara
    Jones, Jennifer
    Markiewicz, Jadwiga
    Painter, Jennifer
    Trust, Carrie
    Wang, Yixin
    Green, George
    JOURNAL OF UROLOGY, 2011, 186 (05): : 2101 - 2106
  • [24] PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml - Editorial comment
    Bartsch, G
    UROLOGY, 2002, 59 (06) : 893 - 894
  • [25] Influence of prostate volume and percent free prostate specific antigen on prostate cancer detection in men with a total prostate specific antigen of 2.6 to 10.0 ng/ml
    Bruno, J. James, II
    Armenakas, Noel A.
    Fracchia, John A.
    JOURNAL OF UROLOGY, 2007, 177 (05): : 1741 - 1744
  • [26] PREVALENCE AND PATHOLOGICAL EXTENT OF PROSTATE-CANCER IN MEN WITH PROSTATE SPECIFIC ANTIGEN LEVELS OF 2.9 TO 4.0 NG/ML
    COLBERG, JW
    SMITH, DS
    CATALONA, WJ
    JOURNAL OF UROLOGY, 1993, 149 (03): : 507 - 509
  • [27] Prostate-specific antigen (PSA) complexed to α1-antichymotrypsin improves prostate cancer detection using total PSA in Japanese patients with total PSA levels of 2.0-4.0 ng/mL
    Kobayashi, T
    Kamoto, T
    Nishizawa, K
    Mitsumori, K
    Ogura, K
    Ide, Y
    BJU INTERNATIONAL, 2005, 95 (06) : 761 - 765
  • [28] Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0 ng/ml
    Ito, K
    Yamamoto, T
    Ohi, M
    Kurokawa, K
    Suzuki, K
    Yamanaka, H
    UROLOGY, 2003, 61 (04) : 760 - 764
  • [29] LOW PERCENTAGE OF FREE PROSTATE-SPECIFIC ANTIGEN IS A STRONG PREDICTOR OF LATER DETECTION OF PROSTATE CANCER AMONG MEN WITH SERUM LEVELS OF TOTAL PSA 4.0 NG/ML OR LESS
    Sasaki, Mitsuharu
    Ishidoya, Shigeto
    Numahata, Kenji
    Arai, Yoichi
    JOURNAL OF UROLOGY, 2015, 193 (04): : E743 - E744
  • [30] Low Percentage of Free Prostate-specific Antigen (PSA) Is a Strong Predictor of Later Detection of Prostate Cancer Among Japanese Men With Serum Levels of Total PSA of 4.0 ng/mL or Less EDITORIAL COMMENT
    Loeb, Stacy
    UROLOGY, 2014, 84 (05) : 1167 - 1167
12345